COMPASS Pathways plc
CMPS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001816590
No open-market purchases or sales by COMPASS Pathways plc insiders were filed in the last 90 days; 224 institutions reported holding it in 13F filings for Q2 2026, worth $1.28B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q4 2023
Institutional positions in COMPASS Pathways plc as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 126
- +13 vs. Q3 2023
- Shares held
- 23.0M
- +697.9K (+3.1%) vs. Q3 2023
- Total value
- $201.1M
- +$36.3M (+22.0%) vs. Q3 2023
- New holders
- 34
- 20 more added
- Sold out
- 21
- 31 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CMPS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 224 | $1.28B |
| Q1 2026 | 194 | $511.5M |
| Q4 2025 | 168 | $379.2M |
| Q3 2025 | 157 | $318.0M |
| Q2 2025 | 140 | $145.1M |
| Q1 2025 | 135 | $148.4M |
| Q4 2024 | 132 | $117.0M |
| Q3 2024 | 130 | $206.5M |
| Q2 2024 | 122 | $172.3M |
| Q1 2024 | 116 | $228.1M |
| Q4 2023 | 126 | $201.1M |
| Q3 2023 | 113 | $164.9M |
| Q2 2023 | 97 | $68.7M |
| Q1 2023 | 103 | $81.3M |
| Q4 2022 | 111 | $61.0M |
| Q3 2022 | 115 | $80.2M |
| Q2 2022 | 108 | $73.8M |
| Q1 2022 | 109 | $99.9M |
| Q4 2021 | 126 | $167.0M |
| Q3 2021 | 118 | $228.7M |
| Q2 2021 | 111 | $294.8M |
| Q1 2021 | 83 | $182.2M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding COMPASS Pathways plc; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 190,232 | $1.66M | 0.00% | −8,872−4.5% | Reduced |
| DAFNA Capital Management LLC | 193,000 | $1.69M | 0.40% | 00.0% | Unchanged |
| Saba Capital Management, L.P. | 201,033 | $1.76M | 0.04% | 00.0% | Unchanged |
| Oasis Management Co Ltd. | 207,911 | $1.82M | 0.62% | 00.0% | Unchanged |
| Putnam Investments LLC | 250,155 | $2.19M | 0.00% | +1,972+0.8% | Added |
| Sio Capital Management, LLC | 251,532 | $2.20M | 0.57% | +251,532 | New |
| Marshall Wace, LLP | 265,613 | $2.32M | 0.00% | +40,809+18.2% | Added |
| ExodusPoint Capital Management, LP | 277,209 | $2.43M | 0.03% | +277,209 | New |
| Founders Fund VII Management, LLC | 278,880 | $2.44M | 10.17% | 00.0% | Unchanged |
| BlackRock Inc. | 305,223 | $2.67M | 0.00% | +13,866+4.8% | Added |
| PFM Health Sciences, LP | 338,761 | $2.96M | 0.18% | +285,890+540.7% | Added |
| Sumitomo Mitsui Trust Holdings, Inc. | 364,962 | $3.19M | 0.00% | −27,370−7.0% | Reduced |
| Nikko Asset Management Americas, Inc. | 364,962 | $3.20M | 0.03% | −27,370−7.0% | Reduced |
| Logos Global Management LP | 500,000 | $4.38M | 0.49% | −450,000−47.4% | Reduced |
| Barclays PLC | 501,310 | $4.39M | 0.00% | +88,244+21.4% | Added |
| Laurion Capital Management LP | 510,907 | $4.47M | 0.16% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 550,000 | $4.81M | 0.96% | +550,000 | New |
| Rosalind Advisors, Inc. | 798,500 | $6.99M | 5.85% | +798,500 | New |
| Aisling Capital Management LP | 964,500 | $8.44M | 2.52% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 964,550 | $8.44M | 0.94% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 1,286,000 | $11.3M | 0.18% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,565,000 | $13.7M | 0.01% | −856−0.1% | Reduced |
| Vivo Capital, LLC | 1,608,000 | $14.1M | 1.15% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 2,265,988 | $19.8M | 0.93% | +907,279+66.8% | Added |
| ARK Investment Management LLCSuperinvestorARK Invest | 2,618,871 | $22.9M | 0.14% | +186,040+7.6% | Added |
| TCG Crossover Management, LLC | 3,858,000 | $33.8M | 3.74% | 00.0% | Unchanged |
| Agf Management Ltd | 0 | $0 | 0.00% | −1,021,545−100.0% | Sold out |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −386,000−100.0% | Sold out |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −328,424−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −80,734−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −21,885−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −20,900−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −15,328−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −11,964−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −11,957−100.0% | Sold out |
| Avantax Advisory Services, Inc. | 0 | $0 | 0.00% | −10,640−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −7,847−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −690−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −324−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −230−100.0% | Sold out |
| Legacy Financial Group LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Authentikos Wealth Advisory, LLC | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| Mark Sheptoff Financial Planning, LLC | 0 | $0 | 0.00% | −53−100.0% | Sold out |
| Impact Partnership Wealth, LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| FinTrust Capital Advisors, LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −64−100.0% | Sold out |